Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
6 studies found for:    Gastrin-releasing peptide receptor
Show Display Options
Rank Status Study
1 Recruiting 68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: 68Ga-RM2 (RM2);   Device: PET/CT Scan
2 Recruiting 68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer
Conditions: Stage II Prostate Adenocarcinoma;   Stage III Prostate Adenocarcinoma;   Stage IV Prostate Adenocarcinoma
Interventions: Procedure: Computed Tomography;   Drug: Gallium Ga 68-labeled GRPR Antagonist BAY86-7548;   Other: Laboratory Biomarker Analysis;   Procedure: Positron Emission Tomography
3 Recruiting 68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer
Condition: Prostate Adenocarcinoma
Interventions: Drug: Gallium Ga 68-labeled GRPR Antagonist BAY86-7548;   Procedure: Magnetic Resonance Imaging;   Procedure: Positron Emission Tomography
4 Completed
Has Results
68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer
Condition: Prostate Carcinoma
Interventions: Drug: 68Ga-DOTA-Bombesin;   Procedure: Magnetic Resonance Imaging (MRI) scan;   Procedure: Positron Emission Tomography (PET) scan
5 Recruiting 68Ga-NOTA-Aca-BBN(7-14) PET/CT in Patients With Primary Gliomas
Condition: Glioma
Interventions: Drug: 68Ga-NOTA-Aca-BBN;   Device: PET/CT
6 Recruiting Detection of Genetic Markers of Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Procedure: Biopsy of the major carinal area;   Procedure: Biopsy of abnormal & suspicious areas of the bronchial tree;   Procedure: Evaluation of the tumor for DNA mutations;   Procedure: Bronchoalveolar Lavage (BAL) for cytokine analysis;   Procedure: Correlation of flow cytometric & RT PCR for TNM stage;   Procedure: Analysis of lymph nodes

Study has passed its completion date and status has not been verified in more than two years.